Tandem Diabetes Care (TNDM) EBT Growth (3y) (2016 - 2026)
Tandem Diabetes Care (TNDM) EBT Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -2.34% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 20.27% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 5.75% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 35.51% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 23.63% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 25.85% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 6.73% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 89.20% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 17.92% |
| 10 | Tandem Diabetes Care | 1.56 Bn | 1.10 Bn | 144.78 Mn | 15.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.76% |
| Mar 31, 2026 | 45.60% |
| Dec 31, 2025 | 31.86% |
| Sep 30, 2025 | 19.02% |
| Jun 30, 2025 | -64.57% |
| Mar 31, 2025 | -95.11% |
| Dec 31, 2024 | -88.70% |
| Sep 30, 2024 | -80.69% |
| Jun 30, 2024 | -109.95% |
| Mar 31, 2024 | -96.62% |
| Dec 31, 2023 | -56.59% |
| Sep 30, 2023 | -48.58% |
| Jun 30, 2023 | -5.82% |
| Mar 31, 2023 | -103.03% |
| Dec 31, 2022 | -99.32% |
| Sep 30, 2022 | -155.80% |
| Jun 30, 2022 | -104.60% |
| Mar 31, 2022 | 10.58% |
| Dec 31, 2021 | 43.73% |
| Sep 30, 2021 | 29.45% |